HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christopher D Willey Selected Research
Christopher D Willey Research Topics
Disease
48
Neoplasms (Cancer)
06/2022 - 04/2007
13
Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2012
9
Lung Neoplasms (Lung Cancer)
01/2021 - 05/2007
8
Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 04/2007
6
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 09/2009
4
Brain Neoplasms (Brain Tumor)
01/2021 - 10/2017
3
Neuroblastoma
06/2022 - 06/2021
3
IGA Glomerulonephritis (IGA Nephropathy)
05/2020 - 01/2014
3
Carcinoma (Carcinomatosis)
01/2020 - 05/2015
3
Squamous Cell Carcinoma of Head and Neck
01/2020 - 06/2011
3
Renal Cell Carcinoma (Grawitz Tumor)
04/2017 - 03/2014
2
Breast Neoplasms (Breast Cancer)
01/2021 - 04/2019
2
Neoplasm Metastasis (Metastasis)
04/2019 - 04/2017
2
Carcinogenesis
03/2017 - 05/2016
2
Hypertrophy
06/2008 - 10/2006
1
Rectal Neoplasms (Rectal Cancer)
01/2022
1
Kidney Diseases (Kidney Disease)
11/2021
1
Residual Neoplasm
01/2021
1
Melanoma (Melanoma, Malignant)
01/2021
1
Deglutition Disorders (Dysphagia)
01/2021
1
Pain (Aches)
01/2021
1
Radiation Pneumonitis
01/2021
1
Hepatoblastoma
01/2021
1
Inflammation (Inflammations)
05/2020
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2020
1
Body Weight (Weight, Body)
01/2020
1
Colorectal Neoplasms (Colorectal Cancer)
10/2019
1
Wilms Tumor (Wilm's Tumor)
09/2019
Drug/Important Bio-Agent (IBA)
16
Phosphotransferases (Kinase)
IBA
01/2020 - 06/2008
11
Proteins (Proteins, Gene)
FDA Link
06/2022 - 10/2006
7
Pharmaceutical Preparations
IBA
01/2022 - 05/2007
7
Peptides (Polypeptides)
IBA
11/2020 - 06/2008
5
Myristoylated Alanine-Rich C Kinase Substrate
IBA
11/2020 - 06/2012
5
Cetuximab (Erbitux)
FDA Link
01/2020 - 06/2009
4
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 06/2009
4
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 05/2007
3
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
06/2022 - 03/2017
3
Small Interfering RNA (siRNA)
IBA
06/2021 - 09/2009
3
Biological Products
IBA
01/2021 - 01/2014
3
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 10/2011
3
Biomarkers (Surrogate Marker)
IBA
10/2020 - 01/2014
3
galactosyl-deficient IgA1
IBA
05/2020 - 01/2014
3
Tyrosine (L-Tyrosine)
FDA Link
04/2017 - 06/2008
2
Focal Adhesion Protein-Tyrosine Kinases
IBA
06/2022 - 09/2019
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 03/2014
2
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2021 - 03/2014
2
Steroids
IBA
01/2021 - 12/2014
2
Ligands
IBA
01/2021 - 01/2020
2
Phospholipids (Phosphatides)
FDA Link
Generic
11/2020 - 06/2019
2
Temozolomide (Temodar)
FDA Link
Generic
11/2020 - 06/2014
2
Autoantigens
IBA
05/2020 - 11/2017
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2020 - 09/2019
2
Transcription Factors (Transcription Factor)
IBA
10/2019 - 07/2015
2
tyrosine receptor (receptor, tyrosine)
IBA
06/2019 - 03/2015
2
Immunoglobulin A (IgA)
IBA
11/2017 - 01/2014
2
matrigel
IBA
08/2010 - 05/2007
1
6- (4- (3- (methylsulfonyl)benzylamino)- 5- (trifluoromethyl)pyrimidin- 2- ylamino)- 3,4- dihydroquinolin- 2(1H)- one
IBA
06/2022
1
muconomycin A
IBA
01/2022
1
peposertib
IBA
01/2022
1
Fluorouracil (Carac)
FDA Link
Generic
01/2022
1
Platelet-Derived Growth Factor
IBA
11/2021
1
Strap protein
IBA
06/2021
1
Ado-Trastuzumab Emtansine
IBA
01/2021
1
Trastuzumab (Herceptin)
FDA Link
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Ipilimumab
IBA
01/2021
1
AZD1208
IBA
01/2021
1
Lipids
IBA
01/2021
1
Oxycodone (Oxycontin)
FDA Link
Generic
01/2021
1
proto-oncogene proteins pim
IBA
01/2021
1
Cadherins (E-Cadherin)
IBA
01/2021
1
Programmed Cell Death 1 Receptor
IBA
01/2021
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
11/2020
1
Leukemia Inhibitory Factor
IBA
05/2020
1
Antigen-Antibody Complex (Immune Complex)
IBA
05/2020
1
Cytokines
IBA
05/2020
1
Autoantibodies
IBA
05/2020
1
Interleukins
IBA
05/2020
1
Oncostatin M
IBA
05/2020
1
8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- one
IBA
01/2020
1
Epidermal Growth Factor (EGF)
IBA
01/2020
1
olaparib
IBA
01/2020
1
thiacloprid
IBA
11/2019
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
09/2019
1
Tensins
IBA
06/2019
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
06/2019
1
Syk Kinase
IBA
04/2019
1
fostamatinib
IBA
04/2019
1
Sialyltransferases
IBA
02/2018
Therapy/Procedure
23
Therapeutics
02/2022 - 05/2009
11
Radiotherapy
01/2022 - 04/2007
4
Drug Therapy (Chemotherapy)
01/2021 - 01/2018
2
Aftercare (After-Treatment)
01/2022 - 09/2009
1
Oncolytic Virotherapy
02/2022
1
Neoadjuvant Therapy
01/2022
1
Analgesia
01/2021
1
Gastrostomy
01/2021
1
Microspheres (Microsphere)
01/2021
1
Artificial Respiration (Mechanical Ventilation)
01/2021
1
Pain Management
01/2021